White Papers

  1. Decentralized Clinical Trials: The Future Of Clinical Research Is Here 12/20/2021

    This white paper provides an introduction to DCTs and summarizes the state of the industry from the perspective of different stakeholders, including the pharmaceutical and medical device industries, regulators across the world, and patients.

  2. Advancing DCTs Through A Unified Approach To eCOA And DHTs 7/6/2021

    Digital health technologies and assessments of patient-reported outcomes are on the rise. Read how uniting the two can better inform how patients experience their disease and respond to treatment.

  3. Transform Your Drug Safety Data And Adjudication Processes With Technology 7/6/2021

    Many may not know that cloud platforms can help streamline clinical endpoint adjudication. Read below to see how these play a role in cutting costs, improving data quality, smoothing regulatory approval, and speeding time to market.

  4. Developing A Mobile Sensor Strategy Journey For Better Study Outcomes 4/15/2021

    With the growth of digital health technologies and an increasingly large selection of possible devices, this white paper highlights considerations as sponsors and CROs develop their DHT strategy.

  5. The Growth Of Phase IV Trials And The Need To Demonstrate Effectiveness Using Electronic Patient Reported Outcomes 7/10/2020

    This paper addresses and describes the growing need to satisfy the value perception of multiple stakeholders and the importance of Late Phase trials capturing Clinical Outcome Assessments (COA) and electronic Patient Reported Outcomes (ePRO) in relation to this.